The first way is via increased hepatic lipogenesis through a decrease in hepatic levels of various proteins (Ptenb, Pparaa and Smad7), identified as potential miR21 target genes in NAFLD progression (Figure 3 and Figure 5). Here, SMAD7 is linked to metabolic dysfunction-associated steatotic liver disease.